Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 3056 of 6372
-
Gut bug may reveal who responds to prostate cancer drug
Knowledge-focused Recruiting nowProstate cancer has the highest incidence and is the second leading cause of cancer death in men in western countries. Androgen deprivation therapy is the backbone treatment. However, after a latency hormone sensitive prostate cancer (HSPC) usually progresses to castration-resist…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Can an AI-Powered app help you shed pounds and keep them off?
Disease control OngoingThis project anticipates addressing the obesity epidemics problem which has caused unhealthy lifestyle in billions of obesities and overweight people worldwide. The investigators propose on digital health solution in providing healthcare-on-demand, for personalized health, health…
Sponsor: National Cheng-Kung University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New heart valve keeps ticking: study tracks safety and performance
Disease control OngoingThe purpose of this study is to characterize the safety and effectiveness of the Medtronic Avalus Ultra aortic valve bioprosthesis in patients with aortic valve disease.
Sponsor: Medtronic Cardiac Surgery • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Needle vs. scalpel: which dialysis access works best?
Disease control OngoingPatients with end-stage kidney disease (ESKD) who use hemodialysis to filter their blood require vascular access for the dialysis machine; the most common type of vascular access is called an arteriovenous fistula (AVF). The AVF is a direct connect between an artery and vein. Un…
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
VR and music: a new way to ease chemo stress?
Symptom relief CompletedThe VRtuose (Virtual RealiTy and mUsic in the Oncology Setting) project aims to evaluate the feasibility of implementing in day patient chemotherapy units a distraction strategy combining virtual reality (VR) and music which fits the needs of both breast cancer patients and healt…
Sponsor: International Agency for Research on Cancer • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New radioactive compound shows promise in targeting Hard-to-Treat cancers
Disease control CompletedThis is a single-center, non-randomized, single-arm, open-label exploratory clinical study of ¹⁷⁷Lu-CTR-FAPI in patients with FAP-high expressing metastatic solid tumors, with a focus on breast cancer, sarcoma, and thyroid cancer. The purpose of this study is to evaluate the saf…
Early phase 1 • Sponsor: Lanzhou University Second Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New MRI scan could spare thousands from unnecessary kidney surgery
Diagnosis OngoingThis study investigates whether new types of MRI scans can tell the difference between different kidney tumours before surgery. Currently, imaging scans can detect kidney tumours and their size, but they aren't effective at determining the tumour type or its aggressiveness. Biops…
Sponsor: University College, London • Aim: Diagnosis
Last updated Jun 26, 2026 17:24 UTC
-
Talking and togetherness: new study aims to lift depression in elderly women
Symptom relief Recruiting nowMental illnesses often go undiagnosed or untreated in low-income settings. Mental health care may be especially important for the elderly - events in the lives of the elderly, like illnesses or deaths of peers, may put these individuals at high risk of mental illness. The study w…
Sponsor: National Bureau of Economic Research, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New combo therapy targets hard-to-treat GI cancers
Disease control Recruiting nowThis is a Phase I study to evaluate the safety and tolerability of sacituzumab govitecan in combination with capecitabine for advanced gastrointestinal cancers after progression on standard therapy, and to assess correlation of outcomes with the biomarker Trop-2.
Phase 1 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Your genes might predict a hidden heart risk
Knowledge-focused Recruiting nowThe goal of this clinical trial is to learn whether a genetic risk score can help identify undiagnosed atrial fibrillation (AF) in adults who may have it. AF is an irregular heartbeat that raises the risk of stroke if not treated early. The main questions it aims to answer are: …
Sponsor: Seoul St. Mary's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Magic mushrooms again? study tests second retreat for cancer anxiety
Symptom relief CompletedThis phase I trial tests the safety and side effects of a second episode of psilocybin-assisted group therapy and how well it works in treating anxiety and distress in patients with cancer that has spread from where it first started (primary site) to other places in the body (met…
Phase 1 • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New hope for kids with rare muscle disease: Long-Term drug safety trial begins
Disease control By invitation onlyThe purpose of this study is to assess the long-term safety and tolerability of an additional 52 weeks of Zilucoplan treatment administered by subcutaneous injection once daily in pediatric study participants
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New acne gel shows promise in large trial
Symptom relief OngoingThe clinical trial aims to test a new drug for acne vulgaris. The trial is performed to answer this question "Is it possible to reduce the number of skin lesions on your face/trunk, after daily applications for 12 consecutive weeks of a new drug?". The trial aims to accurately me…
Phase 3 • Sponsor: PPM Services S.A. • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New sleep program aims to help kids with epilepsy and their parents rest better
Symptom relief Recruiting nowSleep problems are more common and more severe in children with epilepsy. The purpose of this study is to develop and evaluate the effect of a clinic-based and technology-supported sleep intervention for improving sleep and health in children with epilepsy and their parents.
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Bladder battle: full or empty to ease radiation side effects?
Symptom relief Recruiting nowThe present study evaluates empty and full bladder protocols for radiation therapy of genitourinary (GU), gynecological (Gyn), and gastrointestinal (GI) malignancies of the pelvis.
Phase 3 • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New drug duo aims to control colorectal cancer
Disease control OngoingThis is a single-arm, interventional, pilot clinical trial. Fifteen evaluable patients will have tumor-informed ctDNA testing at baseline and start botensilimab and balstilimab treatment. They will receive botensilimab and balstilimab in 6-week cycles until progression, after whi…
Phase 2 • Sponsor: Nicholas DeVito, MD • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Breathwork breakthrough? SKY program may ease cravings in recovery
Symptom relief CompletedEmotional wellness can play a vital role in supporting recovery from substance use disorder (SUD). Developing skills to regulate emotions and manage stress during early stages of recovery can help manage triggers and prevent relapse. Controlled breathing (i.e., intentional manipu…
Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Brain wave test may unlock secrets of chronic pain
Diagnosis OngoingIn this study the investigators aim to assess the correlates of neurophysiological measures (measurement of brain magnetically evoked response) using DELPHI system. The DELPHI system device is a computerized, electromechanical medical device that produces and delivers non-invasiv…
Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
New inhaled drug hopes to clear lungs in mucus diseases
Symptom relief Recruiting nowThis study evaluates the safety, tolerability, and activity of inhaled GDC-6988 in participants with muco-obstructive disease.
Phase 1 • Sponsor: Genentech, Inc. • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New limpet device aims to stop ostomy leaks and skin woes
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and effectiveness of the Limpet, as compared to standard of care ostomy pouches, in reducing complications for ostomy and fistula patients. Secondary objectives include evaluating dressing leak rates and causes of complica…
Sponsor: HealthPartners Institute • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC